Skip to main content
. 2019 May 10;22(5):e25282. doi: 10.1002/jia2.25282

Figure 2. PrEP coverage and cost‐effectiveness.

Figure 2

Lifetime horizon life‐years gained (A), incremental costs (B), and costs per life‐year gained (C) relative to the reference scenario are plotted as a function of coverage for age‐based or incidence‐based PrEP implementation in scenarios of 56% (ASPIRE) or 37% (RING) PrEP effectiveness. PrEP, pre‐exposure prophylaxis.